In addition, the concept that there was a mutually exclusive RB-cyclin–CDKN2A tumor suppressor pathway and that this pathway can be inactivated by either mutational or epigenetic alterations in various human cancers was discovered using lung cancer cell lines [20,21]. Here, RB1 is linked to lung carcinoma.